81033-035-14 : NDC 2026 Code

81033-035-14 : Topiramate ( Topiramate )

Additionally :

You can get information about “81033-035-14” NDC code in 81033-035-14 in HTML format

HTML | 81033-035-14 in TXT (Plain Text) format

TXT | 81033-035-14 in PDF (Portable Document Format)

PDF | 81033-035-14 in XML format

XML formats.

NDC Code : 81033-035-14 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "81033-035-14",
    "PackageDescription": "10 CUP, UNIT-DOSE in 1 CARTON (81033-035-14)  / 4 mL in 1 CUP, UNIT-DOSE (81033-035-04) ",
    "NDC11Code": "81033-0035-14",
    "ProductNDC": "81033-035",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Topiramate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Topiramate",
    "DosageFormName": "SOLUTION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250707",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA217795",
    "LabelerName": "Kesin Pharma",
    "SubstanceName": "TOPIRAMATE",
    "StrengthNumber": "25",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-07-01",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260701",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}